Clinicopathological Value of p16 Expression in Colorectal Carcinoma
Recruiting now
Conditions studied: Colorectal Carcinoma
In brief
Evaluation of the immunohistochemical expression of p16 in colorectal carcinoma and correlate its expression to different clinical and pathological parameters as patients' ages, sexes, tumor location, histopathological phenotype, status of nodal involvement, perineural and lymphovascular invasion.
Key facts
- Study ID
- NCT07047482
- Run by
- Sohag University
- People needed
- 50
- Starts
- 2025-05-01
- Expected to finish
- 2026-12-30
- Last updated by the study team
- 2025-07-10
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Specimens from patients with colorectal cancer.
- Tissue blocks with sufficient material.
- Specimens with sufficient clinical data.
You may not qualify if…
- Tissue blocks with insufficient, destroyed or necrotic material.
- Specimens with insufficient clinical data.
Where it is running
- Faculty of Medicine — Sohag, Recruiting, Egypt (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.